Studies on some metabolic effects of dopa and dopamine in the rat.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000009:adverse effects / Q000494:pharmacology*; D018492:Dopamine Antagonists; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005990:Glycerol / Q000097:blood; D006892:Hydroxydopamines / Q000494:pharmacology; D006943:Hyperglycemia / Q000139:chemically induced; D007773:Lactates / Q000378:metabolism; D050356:Lipid Metabolism; D008297:Male; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D014439:Tyramine / Q000037:antagonists & inhibitors / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D001786:Blood Glucose; D018492:Dopamine Antagonists; D005230:Fatty Acids, Nonesterified; D006892:Hydroxydopamines; D007773:Lactates; D011412:Propanolamines; D011773:Pyruvates; D011941:Receptors, Adrenergic; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D010293:Pargyline; D005990:Glycerol; D004878:Ergotamine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine; D010646:Phentolamine